Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Endocrinol. 2020 Jan;244(1):237–247. doi: 10.1530/JOE-19-0259

Figure 3. Effects of L - and T -type calcium channels on basal aldosterone secretion from human adrenal slices.

Figure 3.

A, Specific L-type channel blocker, nifedipine (500 nmol/L), inhibits basal aldosterone production from human adrenal slices (left); Statistical analysis of nifedipine induced inhibition of aldosterone secretion from human adrenal slices (right). Data expressed as fold over control. **P < 0.01 compared with control (n = 10). B, Specific T-type channel blocker TTA-P2 (2 μmol/L) reduced basal aldosterone production from human adrenal slices (left); Statistical analysis of TTA-P2 induced inhibition of aldosterone secretion from human adrenal slices (right). **p < 0.01 compared with control (n = 11). (S1–19 = samples from different individual patients).